🇺🇸 FDA

Intelligence · Patent portfolio

Xenon Pharmaceuticals Patents

Full USPTO pharma patent portfolio for Xenon Pharmaceuticals — grant dates, expiration, and drug cross-links.

Patents
106
Expiring ≤24m
5

Quick answer

Xenon Pharmaceuticals has 106 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 5 expire within 24 months — use filters for patent-cliff planning.

Page 1 of 3

  1. US 12319657

    Solid state crystalline forms of a selective potassium channel modulator

    Expires Mon May 29 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 12178811

    Methods of treating depressive disorders

    Expires Mon Dec 26 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 12171759

    Methods and uses for treating anhedonia

    Expires Mon Dec 19 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 11957675

    Methods and uses for treating anhedonia

    Expires Mon Apr 11 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 11325902

    Benzenesulfonamide compounds and their use as therapeutic agents

    Expires Mon May 05 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. US 11299490

    Benzenesulfonamide compounds and their use as therapeutic agents

    Expires Mon Apr 07 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  7. US 11203572

    Substituted benzamides and methods of use thereof

    Expires Mon Dec 16 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  8. US 11174268

    Benzenesulfonamide compouds and their use as therapeutic agents

    Expires Mon Nov 11 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  9. US 11149002

    Therapeutic compounds and methods of use thereof

    Expires Mon Oct 14 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  10. US 11135214

    Methods for enhancing the bio availability and exposure of a voltage-gated potassium channel opener

    Expires Mon Sep 30 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  11. US 11130726

    Therapeutic compounds and methods of use thereof

    Expires Mon Sep 23 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  12. US 11091441

    Solid state crystalline forms of a selective potassium channel modulator

    Expires Mon Aug 12 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  13. US 10899732

    Substituted benzamides useful as sodium channel blockers

    Expires Mon Jan 21 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  14. US 10815229

    Benzenesulfonamide compounds and their use as therapeutic agents

    Expires Mon Oct 22 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  15. US 10787446

    Therapeutic compounds and methods of use thereof

    Expires Mon Sep 24 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  16. US 10766858

    Substituted benzamides and methods of use thereof

    Expires Mon Sep 03 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  17. US 10752623

    Heteroaryl-substituted sulfonamide compounds and their use as sodium channel inhibitors

    Expires Mon Aug 20 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  18. US 10745392

    Benzenesulfonamide compounds and their use as therapeutic agents

    Expires Mon Aug 13 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  19. US 10662184

    Benzenesulfonamide compounds and their use as therapeutic agents

    Expires Mon May 21 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  20. US 10526285

    Therapeutic compounds and methods of use thereof

    Expires Mon Jan 02 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  21. US 10513526

    Solid state forms of spiro-oxindole compounds

    Expires Mon Dec 19 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  22. US 10457654

    Therapeutic compounds and methods of use thereof

    Expires Mon Oct 24 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  23. US 10246453

    Benzenesulfonamide compounds and their use as therapeutic agents

    Expires Mon Mar 28 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  24. US 10179767

    Substituted benzamides and methods of use thereof

    Expires Mon Jan 10 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  25. US 10125098

    Therapeutic compounds and methods of use thereof

    Expires Mon Nov 08 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  26. US 10118932

    Solid state forms of spiro-oxindole compounds

    Expires Mon Nov 01 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  27. US 10071957

    N-substituted benzamides and methods of use thereof

    Expires Mon Sep 06 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  28. US 10005724

    Therapeutic compounds and methods of use thereof

    Expires Mon Jun 21 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  29. US 9771376

    N-substituted benzamides and methods of use thereof

    Expires Mon Sep 21 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  30. US 9695185

    Synthetic methods for spiro-oxindole compounds

    Expires Mon Jun 29 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  31. US 9694002

    Substituted benzamides and methods of use thereof

    Expires Mon Jun 29 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  32. US 9630929

    Benzenesulfonamide compounds and their use as therapeutic agents

    Expires Mon Apr 20 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  33. US 9550775

    Substituted triazolopyridines and methods of use thereof

    Expires Mon Jan 19 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  34. US 9546164

    Substituted benzamides and methods of use thereof

    Expires Mon Jan 12 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  35. US 9504671

    Pharmaceutical compositions of spiro-oxindole compound for topical administration and their use as therapeutic agents

    Expires Mon Nov 24 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  36. US 9493429

    Substituted benzoxazoles and methods of use thereof

    Expires Mon Nov 10 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  37. US 9487535

    Asymmetric syntheses for spiro-oxindole compounds useful as therapeutic agents

    Expires Mon Nov 03 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  38. US 9481677

    Biaryl ether sulfonamides and their use as therapeutic agents

    Expires Mon Oct 27 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  39. US 9480677

    Enantiomers of spiro-oxindole compounds and their uses as therapeutic agents

    Expires Mon Oct 27 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  40. US 9458178

    Spiro-oxindole compounds and their use as therapeutic agents

    Expires Mon Sep 29 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  41. US 9278088

    Methods for identifying analgesic agents

    Expires Mon Mar 03 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  42. US 9260446

    Synthetic methods for spiro-oxindole compounds

    Expires Mon Feb 11 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  43. US 9187426

    Organic compounds

    Expires Mon Nov 12 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  44. US 9086420

    Methods for identifying analgesic agents

    Expires Mon Jul 16 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  45. US 8952169

    N-substituted benzamides and methods of use thereof

    Expires Mon Feb 05 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  46. US 8933236

    N-substituted benzamides and methods of use thereof

    Expires Mon Jan 08 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  47. US 8916580

    Spiro-oxindole compounds and their use as therapeutic agents

    Expires Mon Dec 18 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  48. US 8883840

    Enantiomers of spiro-oxindole compounds and their uses as therapeutic agents

    Expires Mon Nov 06 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

How many patents does Xenon Pharmaceuticals have?

106 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).

When do Xenon Pharmaceuticals patents expire?

5 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.

Where does this data come from?

USPTO PatentsView bulk data filtered to pharmaceutical CPC classes (A61K, A61P), cross-linked to NovaPharmaNews company and drug profiles. See our data sources page for methodology.

Data attribution: Data sources · Patent directory

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.